TURVO Business Summary

Turvo International Co., Ltd. (2233.TW) is a premier OEM/ODM manufacturer of high-precision metal components, generating revenue through the fabrication and global distribution of mission-critical parts for highly regulated industries. The company’s business is structured into four primary segments: Automotive (fuel injection, transmission, and chassis systems), Medical (surgical instruments and orthopedic implants), Industrial (high-pressure sensors and connectors), and Aerospace. The Automotive segment remains the dominant revenue driver, anchored by long-standing partnerships with global Tier-1 giants such as Bosch, Denso, and BorgWarner. In the competitive landscape, Turvo contends with precision engineering firms like FineTek (4536.TW), Shieh Yih Machinery (4533.TW), and Apex Dynamics (4583.TW). Turvo distinguishes itself as a high-barrier-to-entry niche player, leveraging advanced multi-axis machining and proprietary surface treatment technologies to maintain superior margins relative to general metal fabricators. The company was founded in 1987 by Chairman Tony Liu (Liu, Chun Chang), whose technical vision transitioned the firm from a local workshop into a global industrial partner. The current executive team is led by Chairman Liu and General Manager James Chen (Chen, Sheng-Hsiung), who oversees operational scaling and supply chain optimization across manufacturing hubs in Taiwan and China. A defining feature of Turvo’s current leadership is its strategic alignment with Excelsior Medical (4126.TW), which became a controlling shareholder in 2022; Excelsior’s Chairman, Lin Zhi-Cheng, serves as a key director on Turvo’s board, facilitating a strategic pivot toward high-margin medical device manufacturing. The board is further supported by institutional investors such as UBS Asset Management and Mega International Investment Trust, reflecting a stable capital structure focused on cross-industry synergies between precision machining and healthcare technology.